Drug Shortage Report for TEVA-PRAVASTATIN
Report ID | 161003 |
Drug Identification Number | 02247010 |
Brand name | TEVA-PRAVASTATIN |
Common or Proper name | PRAVASTATIN 40MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PRAVASTATIN SODIUM |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 P pack |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-05-18 |
Estimated end date | 2022-12-30 |
Actual end date | 2022-12-21 |
Shortage status | Resolved |
Updated date | 2022-12-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.